Amarin Corp (AMRN): Forward P/E Multiple

AMRN (amarincorp.com) - company brandmark

The market value dynamics of Amarin Corporation plc (AMRN), which focuses on the development of cardiology treatments, are recorded at 0.00. Production relies on external contractors for fatty acid synthesis under strict quality control. Meanwhile, management is fighting for the market position of its core product by reducing costs and expanding into foreign markets to ensure financial stability.

Future Price to Earnings Multiple: amarincorp.com (AMRN) for 07/04/2022 - 11/17/2026

Amarin (AMRN) - metric breakdowns and financial figures

- stock value and consensus price forecast:
- stock exchange capitalization data:
Fundamental valuation:Amarin Pharma
Signature product of amarincorp.com

Amarin Corporation plc (AMRN) builds its fundamental value on a strategic bet on highly qualified cardio-pharmaceuticals and FDA standards. The company's forward P/E ratio is calculated by dividing the current share price by the expected annual earnings. The dynamics of this metric determine market optimism regarding future profits. High values signal that the asset is overbought, while low values indicate it is undervalued. This chart helps investors precisely determine the entry point.